[Federal Register: September 5, 2003 (Volume 68, Number 172)]
[Notices]               
[Page 52775-52776]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05se03-66]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
General and Plastic Surgery Devices Panel of the Medical Devices 
Advisory Committee; Notice of Meeting

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: General and Plastic Surgery Devices Panel of the 
Medical Devices Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on October 14, 2003, from 8 
a.m. to 10 p.m., and October 15, 2003, from 7:30 a.m. to 5 p.m.
    Location: Gaithersburg Marriott, Grand Ballroom, 9751 Washingtonian 
Blvd., Gaithersburg, MD.
    Contact Person: David Krause, Center for Devices and Radiological 
Health (HFZ-410), Food and Drug Administration, 9200 Corporate Blvd., 
Rockville, MD 20850, 301-594-3090, ext. 141, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12519. Please call the Information Line or access the 
Internet at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/cdrh/panelmtg.html for up-to-date 
information on this meeting.
    Agenda: On October 14 and 15, 2003, the committee will discuss, 
make recommendations, and vote on a premarket approval application for 
Silicone Gel-Filled Breast Prostheses. Background information, 
including the agenda and questions for the committee, will be available 
to the public on October 10, 2003, on the Internet at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/cdrh/panelmtg.html
.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by September 30, 
2003. Oral presentations from the public will be scheduled on October 
14, 2003, between approximately 8 a.m. and 12 noon, and on October 15, 
2003, between approximately 7:30 a.m. and 11:30 a.m. Time allotted for 
each presentation is limited. Those desiring to make formal

[[Page 52776]]

oral presentations should notify the contact person before September 
30, 2003, and submit a brief statement of the general nature of the 
comments they wish to present, and the names and addresses of proposed 
participants.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact AnnMarie Williams, 
Conference Management Staff, at 301-594-1283, ext. 113, at least 7 days 
in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: August 29, 2003.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 03-22580 Filed 9-4-03; 8:45 am]

BILLING CODE 4160-01-S